Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7091252 | 0.82 | TDP1 (0.45) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 | |
| SCHEMBL21531456 | 0.80 | CYP3A4 (0.39) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 | |
| SCHEMBL6253697 | 0.79 | ALDH1A1 (0.42) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 | |
| SCHEMBL5147091 | 0.78 | ALDH1A1 (0.44) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 | |
| SCHEMBL37582 | 0.76 | TDP1 (0.34) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 | |
| SCHEMBL83320 | 0.76 | TDP1 (0.34) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 | |
| SCHEMBL340855 | 0.74 | ALDH1A1 (0.48) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 | |
| SCHEMBL8906728 | 0.73 | ALDH1A1 (0.34) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 | |
| SCHEMBL1822785 | 0.72 | TDP1 (0.56) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 | |
| SCHEMBL10375177 | 0.72 | CYP3A4 (0.43) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0544795-B2 | SEMICONDUCTIVE COPOLYMERS FOR USE IN LUMINESCENT DEVICES | CAMBRIDGE DISPLAY TECH LTD (GB) | 2003-04-09 | — | — | EP | claimed |
| EP-0704094-B1 | POLYMERS FOR OPTICAL DEVICES | CAMBRIDGE DISPLAY TECH LTD (GB) | 2001-08-08 | — | — | EP | claimed |
| EP-0544795-B1 | SEMICONDUCTIVE COPOLYMERS FOR USE IN LUMINESCENT DEVICES | CAMBRIDGE DISPLAY TECH LTD (GB) | 1999-04-28 | — | — | EP | claimed |
| US-5512654-A | Semiconductive copolymers for use in luminescent devices | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 1996-04-30 | — | — | US | claimed |
| EP-0704094-A1 | POLYMERS FOR OPTICAL DEVICES | Cambridge Display Technology Limited (GB) | 1996-04-03 | — | — | EP | claimed |
| US-5425125-A | Optical device incorporating semiconductive conjugated polymer | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 1995-06-13 | — | — | US | claimed |
| US-5401827-A | Semiconductive copolymers for use in luminescent devices | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 1995-03-28 | — | — | US | claimed |
| WO-1994029883-A1 | POLYMERS FOR OPTICAL DEVICES | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 1994-12-22 | — | — | WO | claimed |
| US-5328809-A | Patterning of semiconductive polymers | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 1994-07-12 | — | — | US | claimed |
| EP-0544795-A1 | SEMICONDUCTIVE COPOLYMERS FOR USE IN LUMINESCENT DEVICES | Cambridge Display Technology Limited (GB) | 1993-06-09 | — | — | EP | claimed |
| WO-1992003490-A1 | SEMICONDUCTIVE COPOLYMERS FOR USE IN LUMINESCENT DEVICES | CAMBRIDGE RESEARCH AND INNOVATION LIMITED (GB) | 1992-03-05 | — | — | WO | claimed |
| US-11585818-B2 | Chromophoric polymer dots | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2023-02-21 | — | — | US | disclosed |
| US-20200371109-A1 | CHROMOPHORIC POLYMER DOTS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2020-11-26 | — | — | US | disclosed |
| US-8207337-B2 | Reagent for organic synthesis reaction containing organic triol borate salt | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-26 | — | — | US | disclosed |
| US-20100087646-A1 | REAGENT FOR ORGANIC SYNTHESIS REACTION CONTAINING ORGANIC TRIOL BORATE SALT | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-08 | — | — | US | disclosed |
| US-5763539-A | Process for producing polymers of α,ω-unsaturated conjugated compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-06-09 | — | — | US | disclosed |
| US-5672678-A | Semiconductive copolymers for use in luminescent devices | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 1997-09-30 | — | — | US | disclosed |
| US-5512654-A | Semiconductive copolymers for use in luminescent devices | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 1996-04-30 | — | — | US | disclosed |
| EP-0705857-A2 | A process for producing polymers of alpha,omega-unsaturated conjugated compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-04-10 | — | — | EP | disclosed |
| US-5401827-A | Semiconductive copolymers for use in luminescent devices | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 1995-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087646-A1 | REAGENT FOR ORGANIC SYNTHESIS REACTION CONTAINING ORGANIC TRIOL BORATE SALT | ORC3, OXSR1, OSTC | CYP3A4 1209/4885L3MBTL1 1985/4885ALDH1A1 4639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.